Compare IOSP & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOSP | LMRI |
|---|---|---|
| Founded | 1938 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 1998 | 2025 |
| Metric | IOSP | LMRI |
|---|---|---|
| Price | $86.88 | $13.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $124.00 | $22.67 |
| AVG Volume (30 Days) | 150.2K | ★ 544.6K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,789,200,000.00 | $1,003,375,000.00 |
| Revenue This Year | N/A | $9.29 |
| Revenue Next Year | $5.06 | $5.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.38 |
| 52 Week Low | $70.10 | $9.97 |
| 52 Week High | $112.93 | $19.45 |
| Indicator | IOSP | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 64.10 | 50.50 |
| Support Level | $85.21 | $9.97 |
| Resistance Level | $87.25 | $14.15 |
| Average True Range (ATR) | 2.18 | 1.10 |
| MACD | 0.40 | 0.31 |
| Stochastic Oscillator | 68.19 | 85.35 |
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.